191916-32-2

Upstream product

• 108-24-7 acetic anhydride 
• 191916-31-1 (3aR,7S,7aR)-7-Allyloxy-2,2-dimethyl-3a,4,7,7a-tetrahydro-benzo[1,3]dioxole-5-carboxylic acid methyl ester 
• 160080-76-2 (3aR,7S,7aS)-7-Hydroxy-2,2-dimethyl-3a,4,7,7a-tetrahydro-benzo[1,3]dioxole-5-carboxylic acid methyl ester 

Downstream Products

• 191916-34-4 (3S,4R,5R)-4,5-Diacetoxy-3-(2-hydroxy-ethoxy)-cyclohex-1-enecarboxylic acid methyl ester 
• 191916-36-6 (3S,4R,5R)-4,5-Diacetoxy-3-(2-oxo-ethoxy)-cyclohex-1-enecarboxylic acid methyl ester 
• 191916-33-3 (3S,4R,5R)-4,5-Diacetoxy-3-(2,3-dihydroxy-propoxy)-cyclohex-1-enecarboxylic acid methyl ester 
• 191916-35-5 (3S,4R,5R)-4,5-Diacetoxy-3-[2-(dimethoxy-phosphoryl)-ethoxy]-cyclohex-1-enecarboxylic acid methyl ester 
• 191916-37-7 (3S,4R,5R)-4,5-Diacetoxy-3-[2-(dimethoxy-phosphoryl)-2-hydroxy-ethoxy]-cyclohex-1-enecarboxylic acid methyl ester 

Relevant academic research and scientific papers

Synthesis and evaluation of 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO8P) synthase inhibitors

Carbocyclic analogues as transition state mechanism based inhibitors of 3-deoxy-D-manno-2-octulosonate-8-phosphate synthase were designed, synthesized, and evaluated for their biological activity.